Fatality

Fatality, in the context of substance use, refers to a death that a coroner, medical examiner, or public health agency has recorded as related to a substance exposure. These records form the statistical base for most public reporting on drug-related deaths.

Attribution is rarely straightforward. Most recorded cases involve more than one substance detected in the body, an underlying medical condition that elevated risk, or physical circumstances — sleeping position, environment, time elapsed before discovery — that were never formally measured. A fatality count describes what was found and documented; it does not describe the risk a substance carries in isolation from those factors.

How it is done

Recording a substance-related fatality typically begins with a toxicology screen: a laboratory analysis of blood, urine, or tissue samples that identifies which compounds were present at the time of death. A coroner or medical examiner then determines the cause and manner of death — drawing on the toxicology result, autopsy findings, and whatever information about circumstances is available.

Different jurisdictions apply different standards. Some count any death where a substance was detected, regardless of whether it contributed causally. Others require the substance to be identified as the primary cause. International figures are unreliable for this reason — two countries' tallies may be built on incompatible definitions while appearing to measure the same thing.

Public health agencies aggregate these records into broader statistics: drug-poisoning deaths, overdose mortality rates, drug-related death counts. Each term carries a slightly different definition. The distinctions matter when reading across reports or comparing figures from different sources.

What it cannot tell you

A fatality count does not establish how dangerous a substance is when used under specific conditions. It captures how often people died with a substance present — not how often people used that substance and survived, and not the degree to which the substance, versus everything else in the picture, was responsible for each death.

The most common misreading is treating a high count as evidence of high inherent lethality. It may instead reflect high prevalence of use, a period of purity or supply-chain variation, or a population carrying elevated vulnerability across several dimensions at once. A low count is equally easy to misread — it may indicate rarity of use rather than relative safety.

Polydrug cases introduce further ambiguity. When two or more compounds appear in a toxicology result, standard records often attribute the death to the compound listed most prominently or first on the death certificate. This can overstate the role of one substance and make the contributions of others invisible.

The count also cannot identify which circumstances changed the outcome. Route, quantity, setting, who else was present, access to emergency intervention and reversal agents — these are the variables that harm reduction methods address. A recorded fatality confirms that they mattered; it does not say which ones, or by how much.